CLASS II Device recall · Reported 28 Jun 2023 · FDA Enforcement Report

MiSeq Dx Instrument recalled by Illumina

Illumina is recalling MiSeq Dx Instrument, distributed nationwide in the US. The recall was initiated on 5 Apr 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUCS Versions: UCS 2.5.0/ UDI-DI: (00)816270020002
Quantity recalled740 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1977-2023
FDA event ID
92233
Recalling firm
Illumina, San Diego, CA
Classification
Class II
Status
Completed
Recall initiated
5 Apr 2023
FDA classified
16 Jun 2023
Reported
28 Jun 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Medical Software

Timeline

5 Apr 2023Recall initiated by company
16 Jun 2023Classified by FDA+72 days
28 Jun 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Cybersecurity vulnerability concerning the software used for sequencing instruments.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

MiSeq Dx Instrument, Catalog # M70101, containing Universal Copy Service (UCS) software.

Where it was distributed

Worldwide distribution - US Nationwide and the countries of Algeria, AU Australia, Austria, Belgium, Bulgaria, Canada, Chile, China, Cyprus, Czech Republic, Denmark, Egypt, FR France, GB Georgia, Germany, Guatemala, Hong Kong, Hungary, IT Italy, Japan, Latvia, Lithuania, Luxembourg, Macedonia, Malta, Morocco, Netherlands, New Zealand, Norway, Philippines, Poland, Portugal, Qatar, Russian Fed., Saudi Arabia, SG Singapore, Slovenia, South Korea, Spain, Sweden, Switzerland, Thailand, United Kingdom, Utd. Arab Emir., Vietnam, Argentina, Aerbaijan, Belgium, Bosnia-Herz., Finland, Greece, Iceland, Ireland, Israel, Japan, Nigeria, NL Norway, Romania, Serbia, Slovakia, South Africa, T¿rkiye, Ukraine.

Nationwide Georgia

Questions about this recall

Why was it recalled?

Cybersecurity vulnerability concerning the software used for sequencing instruments.

Which lots are affected?

UCS Versions: UCS 2.5.0/ UDI-DI: (00)816270020002

Where was it sold?

Worldwide distribution - US Nationwide and the countries of Algeria, AU Australia, Austria, Belgium, Bulgaria, Canada, Chile, China, Cyprus, Czech Republic, Denmark, Egypt, FR France, GB Georgia, Germany, Guatemala, Hong Kong, Hungary, IT Italy, Japan, Latvia, Lithuania, Luxembourg, Macedonia, Malta, Morocco, Netherlands, New Zealand, Norway, Philippines, Poland, Portugal, Qatar, Russian Fed., Saudi Arabia, SG Singapore, Slovenia, South Korea, Spain, Sweden, Switzerland, Thailand, United Kingdom, Utd. Arab Emir., Vietnam, Argentina, Aerbaijan, Belgium, Bosnia-Herz., Finland, Greece, Iceland, Ireland, Israel, Japan, Nigeria, NL Norway, Romania, Serbia, Slovakia, South Africa, T¿rkiye, Ukraine.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 92233
ReportedClassRecallCompanyReasonWhere
CLASS IINextSeq 550Dx Instrument recalled by IlluminaIlluminaDevice MalfunctionNationwide

More recalls from Illumina

All 10

Other Medical Software recalls

All 932